Mechanism/Kinetics of the Traceless Staudinger Ligation
A R T I C L E S
been prelocked on a sample containing 13C-labeled azide in 700 µL of
DMF/D2O (6:1). After an initial delay of 45 s, the acquisition of NMR
spectra was initiated. 90 spectra were acquired over a scaled time course
of 16 h (15 spectra during the first 15 min, 15 spectra during the next
30 min, 15 spectra during the next 60 min, 15 spectra during the next
120 min, 15 spectra during the next 240 min, and 15 spectra during
the final 480 min). Each time point was designed to consume 44 s,
with the remaining time being a preacquisition delay before the next
scan. An appropriate flip angle (30° pulse) and relaxation delay (10 s)
were chosen to obtain fully quantitative spectra at each time point and
for each intermediate. In addition, the decoupler was turned on solely
during the acquisition to prevent any NOE buildups. To confirm that
the NMR-based assay provided quantitative results, a standard curve
was made for each starting material and available intermediate and
shown to correlate well with the spectral integration during a reaction.
General Procedures for Staudinger Ligations. Unless noted
otherwise, Staudinger ligations were performed at room temperature
with equimolar amounts of phosphinothioester (or phosphinoester) and
azide (0.105 mmol) in DMF/D2O (6:1; 600 µL).
The spectral data for the isolated and synthesized compounds were
indistinguishable.
Spectral Data. H NMR (CD3OD, 400 MHz) δ 7.91-7.86 (m, 5
1
H), 7.55-7.50 (m, 5H), 7.34-7.26 (m, 5H), 4.42 (s, 2H), 3.94 (s, 2H)
ppm; 13C NMR (CD3OD, 125 MHz) δ 168.63, 138.19, 134.06, 132.75,
131.63, 131.60, 131.42, 131.32, 128.26, 128.18, 128.12, 127.22, 126.94,
51.71, 42.69 ppm; 31P NMR (CD3OD, 161 MHz) δ 24.55 ppm; MS
(ESI) m/z 388.1251 (MNa+ [C2013CH21N2O2PNa+] ) 388.1266).
GlyNHBn (19) and AspNHBn (20). Amines 19 (which is unlabeled
16)43 and 2044 were prepared according to procedures reported
previously. Spectral Data. Spectral data were as reported previously.43,44
AcGlySCH2C(O)NHMe (21). N-Acetylglycine (4.0 g, 34.2 mmol)
was dissolved in anhydrous DMF (100 mL). DCC (7.06 g, 34.2 mmol)
was then added. Once precipitate (DCU) was observed, N-methyl
mercaptoacetamide was added (3.6 g, 34.2 mmol). The reaction mixture
was allowed to stir under Ar(g) for 18 h. The precipitate was removed
by filtration, and the filtrate was concentrated under reduced pressure
to give a white solid. The solid was dissolved in ethyl acetate and
purified by flash chromatography (silica gel, ethyl acetate/hexanes).
Thioester 21 was isolated as an off-white solid in 91% yield. Spectral
AcGlySCH2PPh2 (11). N-Acetylglycine (1.90 g, 16.2 mmol) was
dissolved in anhydrous DMF (75 mL). HOBt (2.48 g, 16.2 mmol) was
added to the resulting solution, followed by DCC (3.34 g, 16.2 mmol).
Once precipitate (DCU) was observed, phosphinothiol 26 was added
(3.77 g, 16.2 mmol). The reaction mixture was allowed to stir under
Ar(g) for 3 h. The precipitate was removed by filtration, and the filtrate
was concentrated under reduced pressure to give a white solid. The
solid was dissolved in ethyl acetate and purified by flash chromatog-
raphy (silica gel, ethyl acetate). Phosphinothioester 11 was isolated in
96% yield. Spectral Data. Spectral data were as reported previously.10
[2-13C]-2-Azido-N-benzyl-acetamide (12). Azide 12 was synthe-
sized from 2-13C bromoacetic bromide via methods reported previously10
and isolated in 98% yield. Spectral Data. 1H NMR (CDCl3, 400 MHz)
δ 7.39-7.27 (m, 5H), 6.71 (bs, 1H), 4.47 (d, J ) 5.7 Hz, 2H), 4.00 (s,
2H) ppm; 13C NMR (CDCl3, 100 MHz) δ 166.66, 137.39, 128.43,
1
Data. H NMR (CDCl3, 400 MHz) δ 6.09 (bs, 1H), 4.26 (bs, 1H),
3.59 (s, 2H), 2.82 (s, 2H), 2.18 (s, 3H), 2.10 (s, 3H) ppm; 13C NMR
(CDCl3/CD3OD (1:1), 125 MHz) δ 196.99, 172.23, 169.07, 31.43,
31.40, 26.04, 25.90, 21.65 ppm; MS (ESI) m/z 227.0457 (MNa+
[C7H12N2O3SNa+] ) 227.0461).
(Diphenylphosphino)methanethiol (22), (o-Diphenylphosphino)-
benzenethiol (23), (diphenylphosphino)methanol (24), (Diphen-
ylphosphino)ethanethiol (25), and (o-Diphenylphosphino)phenol
(26). Compounds 22,11 23,9 24,39 25,41 and 2639 were prepared according
to reports published previously. Spectral Data. Spectral data were as
reported previously.9,11,39,41
AcGlyOCH2PPh2 (27). N-Acetylglycine (1.12 g, 10.0 mmol) was
dissolved in anhydrous CH2Cl2 (30 mL). DMAP (0.12 g, 1.0 mmol)
was added to the resulting solution, followed by DCC (2.06 g, 10.0
mmol). Once precipitate (DCU) was observed, (diphenylphosphino)-
methanol (24; 2.16 g, 10.0 mmol) was added, and the reaction mixture
was allowed to stir under Ar(g) for 18 h. The precipitate was removed
by filtration, and the filtrate was concentrated under reduced pressure
to give a clear oil. The oil was dissolved in ethyl acetate and purified
by flash chromatography (silica gel, ethyl acetate/hexanes). Phosphi-
noester 27 was isolated as a colorless oil in 56% yield. Spectral Data.
1H NMR (CDCl3, 400 MHz) δ 7.47-7.42 (m, 4H), 7.39-7.37 (m,
6H), 5.89 (bt, 1H), 4.92 (d, J ) 6.2 Hz, 2H), 3.98 (d, J ) 5.0 Hz, 2H),
2.00 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz) δ 185.35, 169.59,
132.65, 132.50, 128.85, 128.27, 128.22, 48.13, 33.27, 25.17, 24.47 ppm;
31P NMR (CDCl3, 161 MHz) δ -20.02 ppm; MS (ESI) m/z 338.0920
(MNa+ [C17H18NO3PNa+] ) 338.0916).
127.45, 127.35, 52.06, 43.08 ppm; MS (ESI) m/z 214.0789 (MNa+ [C813
CH10N4ONa+] ) 214.0780).
-
AcGly[13CR]GlyNHBn (15). Amide 15 was synthesized by using
the general procedures for Staudinger ligation (vide supra). Spectral
Data. Spectral data were the same as reported previously.10
[13CR]GlyNHBn (16). Azide 12 (951 mg, 5.0 mmol) was dissolved
in anhydrous THF (30 mL) in a flame-dried flask under Ar(g). Ethyl
diphenyl phosphine (1.29 g, 6.0 mmol) was added to the resulting
solution, which was then allowed to stir under Ar(g) for 8 h. Water
(3.3 mL, to 10% v/v) was added, and the reaction mixture was stirred
for an additional 1 h. The solvent was then removed under reduced
pressure, and the resulting oil was purified by flash chromatography
(silica gel, 3% v/v MeOH in CH2Cl2). Amine 16 was isolated in 97%
yield as a clear oil. Spectral Data. Spectral data were the same as
reported previously.43
AcGlySCH2CH2PPh2 (31). N-Acetylglycine (475 mg, 4.06 mmol)
was dissolved in anhydrous DMF (20 mL). HOBt (549 mg, 4.06 mmol)
was added to the resulting solution, followed by DCC (838 mg, 4.06
mmol). Once precipitate (DCU) was observed, (diphenylphosphino)-
ethanethiol (25; 1.0 g, 4.06 mmol) was added. The reaction mixture
was allowed to stir under Ar(g) for 3 h. The precipitate was removed
by filtration, and the filtrate was concentrated under reduced pressure
to give a clear oil. The oil was dissolved in ethyl acetate and purified
by flash chromatography (silica gel, 70% v/v ethyl acetate in hexanes).
Phosphinoester 31 was isolated as a white solid in 92% yield. Spectral
Ph2P(O)[13CR]GlyNHBn (17). Phosphonamide 17 was isolated from
a Staudinger ligation of phosphinothioester 11 and azide 12, performed
as described above. The solvent of the reaction was removed under
reduced pressure, and the resulting oil was washed with CH2Cl2. The
suspension was filtered, and phosphonamide 17 was isolated in 1%
yield.
Phosphonamide 17 was also synthesized directly by the reaction of
diphenylphosphinic chloride and GlyNHBn (16). Diphenylphosphinic
chloride (1.0 g, 4.2 mmol) was dissolved in anhydrous THF (20 mL).
DMAP (60 mg, 0.5 mmol) was added to the resulting solution, followed
by GlyNHBn (700 mg, 4.2 mmol). The reaction mixture was allowed
to stir under Ar(g) for 8 h. The solvent was then removed under reduced
pressure, and the resulting oil was purified by flash chromatography
(silica gel, 3% v/v MeOH in CH2Cl2). Phosphonamide 17 was isolated
in 81% yield.
1
Data. H NMR (CDCl3, 400 MHz) δ 7.47-7.43 (m, 4H), 7.37-7.36
(m, 6H), 6.06 (bs, 1H), 4.20 (d, J ) 5.6 Hz, 2H), 3.00 (m, 2H), 2.46
(m, 2H), 2.07 (s, 3H) ppm; 13C NMR (CDCl3, 125 MHz) δ 196.78,
170.65, 137.23, 137.14, 132.68, 132.52, 128.81, 128.53, 128.47, 126.33,
125.53, 49.15, 28.27 (d, J ) 15.4 Hz), 25.60 (d, J ) 23.1 Hz), 22.81
ppm; 31P NMR (CDCl3, 161 MHz) δ -19.88 ppm; MS (ESI) m/z
368.0852 (MNa+ [C18H20NO2PSNa+] ) 368.0845).
(43) Balboni, G.; Guerrini, R.; Salvadori, S.; Bianchi, C.; Rizzi, D.; Bryant, S.
(44) van Leeuwen, S. H.; Quaedflieg, P.; Broxterman, Q. B.; Liskamp, R. M.
D.; Lazarus, L. H. J. Med. Chem. 2002, 45, 713-720.
J. Tetrahedron Lett. 2002, 43, 9203-9207.
9
J. AM. CHEM. SOC. VOL. 128, NO. 27, 2006 8827